日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study

瑞维替尼治疗伴有中枢神经系统转移的EGFR突变型非小细胞肺癌患者:来自III期REZOR研究的中枢神经系统疗效

Yang, Sheng; Zhao, Yanqiu; Sun, Meili; Bi, Minghong; Zhu, Bo; Chen, Zhaohong; Yu, Huiqing; Zhang, Liangming; Wu, Lin; Zhou, Rui; Yao, Wenxiu; Li, Xingya; Han, Zhigang; Wang, Ke; Wang, Lijun; Wen, Meiling; Guo, Yanzhen; Lin, Yingcheng; Sun, Shenghua; Guo, Shuliang; Yi, Tienan; Zhao, Wenhua; Yu, Zhuang; Qin, Jianwen; Pan, Yueyin; He, Zhiyong; Ye, Feng; Shi, Huaqiu; Fang, Jian; Ma, Rui; Lu, Hong; Zhang, Hua; Shi, Jianhua; Gao, Jinghua; Cui, Jiuwei; Li, Manxiang; Yi, Shanyong; Cang, Shundong; Shu, Yongqian; Zhang, Don; Peng, Jirong; Gao, Feng; Wang, Tingting; Zhou, Anqi; Shi, Yuankai

Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma.

靶向富含亮氨酸重复激酶 2 可克服胶质母细胞瘤对溶瘤性单纯疱疹病毒疗法的耐药性。

Qin Yaning, Liang Zhiqi, Yu Mengqin, Lin Nanqian, Wang Naizhen, Huang Xuanke, Chen Shi, Peng Qun, Lin Yanhua, Wang Heqin, Rao Yipeng, Xu Zilong, Huang Shenghua, Cai Jingjing, Li Yukui, Zhang Jun, Lin Chaolong, Tan Guowei, Xia Ningshao, Huang Chenghao

PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells

PhenoModel:一种用于发现多种癌细胞新型潜在抑制剂的多模态表型药物设计基础模型

Wang, Shihang; Han, Qilei; Qin, Weichen; Wang, Lin; Yuan, Junhong; Cai, Fengyu; Zhao, Yiqun; Ren, Pengxuan; Zhang, Yunze; Tang, Yilin; Li, Ruifeng; Li, Zongquan; Zhang, Wenchao; Gao, Shenghua; Bai, Fang

Structural biology of HIV-1 reverse transcriptase allosteric inhibitors for drug design

HIV-1逆转录酶变构抑制剂的结构生物学及其在药物设计中的应用

Zhou, Zhenzhen; Sun, Yanying; Feng, Da; Wang, Zhao; Zhao, Fabao; Gao, Shenghua; Zhan, Peng; Kang, Dongwei; Liu, Xinyong

Multi-Tissue Omics Analysis Uncovers Translational Regulation Underlying Complex Traits in Pigs

多组织组学分析揭示猪复杂性状的翻译调控机制

Wang, Chao; Zhang, Yuanyuan; Chen, Choulin; Xu, Xiaoxian; Qin, Shenghua; Qi, Junyan; Bao, Yongzhou; Li, Huiming; Chen, Ruipu; Zheng, Weigang; Chen, Zhilong; Fang, Lingzhao; Zhao, Yunxiang; Liu, Yuwen

BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares

BCMA/CD19 CAR T 细胞疗法治疗难治性重症肌无力:疾病发作的蛋白质组学特征和单细胞转录组学

Huang, Xiaoyu; Zhang, Zhouao; Liu, Dan; Luo, Tiancheng; An, Xueting; Yang, Mingjin; Li, Shengli; Wang, Gang; Li, Huizhong; Cao, Jiang; Sun, Zengtian; Du, Xue; Wang, Zhouyi; Guo, Xinyan; Ma, Tianyu; Peng, Deyou; Qi, Guoyan; Zong, Shenghua; Ding, Yanting; Cui, Guiyun; Shi, Ming; Zheng, Junnian; Zhang, Yong

Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.

癌细胞衍生的唾液酸化 IgG 与 Siglec-7/9/10 相互作用,是胰腺癌潜在的免疫治疗靶点。

Zhang Shenghua, Cui Ming, Huang Xinmei, Feng Xiaoyao, Xiao Ruiling, Liu Qijia, Bai Jialu, Han Xianlin, Liu Xiaoding, Xu Weiyan, Huang Jing, Liao Quan, Zhao Yupei, Qiu Xiaoyan

Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment: mechanisms and therapeutics

剖析表观遗传调控在口腔鳞状细胞癌微环境中的作用:机制和治疗方法

Li, Xuechao; Ren, Yifei; Pei, Shenghua; Zhao, Kai; Chen, Guanyu; He, Zhenglin

MARCH1 Deletion Attenuates HFpEF by Promoting Adipose Beiging

MARCH1基因缺失通过促进脂肪组织褐变来减轻HFpEF症状。

Zhu, Yunlong; Fan, Jie; Tang, Liang; Zhou, Yuying; Jiang, Kang; Tan, Dan; Huang, Haobo; Wu, Mingxing; Zeng, Jianping; Yang, Hui; Zhou, Shenghua

The influence of washed microbiota transplantation on menstruation in female patients of childbearing age

洗涤后的微生物群移植对育龄女性患者月经的影响

Wu, Qingting; Wang, Mingzhu; Yang, Juan; Wang, Jiangyan; Feng, Shuo; Lu, Shenghua; Qin, Zhichu; He, Xingxiang; Wu, Lei